Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease precocious puberty
Phenotype C0242292|albright syndrome
Sentences 4
PubMedID- 22051789 Three atypical cases of suspected mccune-albright syndrome with gonadotropin-independent precocious puberty are presented.
PubMedID- 22999294 The objective of this study was to evaluate the safety and efficacy of fulvestrant (faslodextm), a pure estrogen receptor antagonist, in girls with progressive precocious puberty (pp) associated with mccune-albright syndrome (mas).
PubMedID- 22654844 Tamoxifen, a first generation serm, has been used to treat pubertal gynecomastia in adolescent boys (derman et al., 2003; lawrence et al., 2004) and precocious puberty in patients with mccune–albright syndrome (eugster et al., 2003).
PubMedID- 23087851 Central precocious puberty may be associated with mccune-albright syndrome and neurofibromatosis type-1 (nf-1).

Page: 1